Latest News
Cooperation on Projects | Leto Laboratories and Hanson Pharmaceutical Entered into Cooperation in Developing a New Drug for Metabolic Diseases
In September 2021, the Hanson Pharmaceutical Group Co., Ltd. (HKEX: 3692) ("Hanson Pharmaceutical") and Leto Laboratories Co., Ltd. ("Leto Laboratories") signed a co-development agreement, in which the parties agreed to carry out a cooperation on metabolic disease projects to facilitate the development and production of a new drug molecule.
Published: September 13, 2021
Latest News
Leto Laboratories Raises over $15 Million in Series B+ Financing Round for Protein Engineering
Leto Laboratories Co., Ltd. ("Leto Labs") announced the closing of a Series B+ financing of over $15.64 Million (RMB 100 million) from China Capital Management Co., Ltd. The company intends to use the proceeds to continue the development of its polypeptides and anticancer cytokines pipeline.
Published: August 4, 2021
No more data……